Nabi Biopharmaceuticals (NABI)
$4.79
-0.11 (-2.24%)
| CAPS Rating |
|
|---|---|
| Open | $5.00 |
| Previous Close | $4.90 |
| Daily Range | $4.73 - $5.07 |
| 52-Week Range | $2.15 - $5.30 |
| Market Cap | $243.15M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 387,131 |
| Average Daily Volume | 462,000 |
NABI
VS S&P 500 (SPY)
How do you think NABI will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
NABI Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
NABI News and Commentary
- This Partnership Is Smoking! – The Motley Fool
- UPDATE 1-Nabi, Glaxo sign nicotine addiction vaccine deal – Reuters
- GlaxoSmithKline, Nabi Biopharmactuticals In Licensing Pact – SmartMoney
- These 5 Underdogs Are No Dogs – The Motley Fool
- 5-Star Stocks on the Upswing – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
- Get Ready for the Bounce – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- 5-Star Stocks on the Upswing – The Motley Fool
- 3 Stocks Hitting High Notes – The Motley Fool
- 3 Stocks Hitting High Notes – The Motley Fool
- Get Ready for the Fall – The Motley Fool
- 3 Stocks Hitting High Notes – The Motley Fool
- Enzon Shareholders Steal the Show – The Motley Fool
- The Start of a New Endo – The Motley Fool
- 7 Highly Rated Stocks on Sale – The Motley Fool
- 5 More Turnaround Stocks – The Motley Fool
- Get Ready for the Bounce – The Motley Fool
- Rise and Shine, Candela – The Motley Fool
RSS Headlines
Fool UK
